Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of GFH312 in Healthy Subjects
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- GenFleet Therapeutics (Australia) Pty Ltd.
- Target Recruit Count
- 76
- Registration Number
- NCT04676711
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
News
No news found